Assure (OTCMKTS:ARHH – Get Rating) and Titan Medical (NASDAQ:TMDI – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Profitability

This table compares Assure and Titan Medical's net margins, return on equity and return on assets.

Institutional and Insider Ownership

0.0% of Assure shares are owned by institutional investors. Comparatively, 3.6% of Titan Medical shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Ratings

Valuation and Earnings

This table compares Assure and Titan Medical's revenue, earnings per share (EPS) and valuation.

Titan Medical has higher revenue and earnings than Assure. Titan Medical is trading at a lower price-to-earnings ratio than Assure, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Assure has a beta of 2.6, suggesting that its share price is 160% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500.

About Assure

(Get Rating)

Assure Holdings Corp. is a Colorado-based company. It works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. It focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. The company was founded by Preston Thomas Parsons on May 24, 2017 and is headquartered in Denver, CO.

About Titan Medical

(Get Rating)

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.